Autism Spectrum Disorder Trial, Recruiting (NCT05726708)

Autism Spectrum Disorder Trial, Recruiting NCT05726708 Sponsor: Centre Hospitalier Universitaire Vaudois Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT05726708 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child has been diagnosed with Autism Spectrum Disorder (ASD)
The child is between 2 years old and 4 years and 6 months old
The family speaks French
A parent or guardian has signed the consent form to agree to participate

Who may not be able to join:

The child has a known genetic condition or syndrome
The child has a known vision or hearing problem
The child has epilepsy (a condition that causes seizures)
The family does not have access to the internet
The family does not speak French

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41314 58 94

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05726708

Sponsor: Centre Hospitalier Universitaire Vaudois

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +41314 58 94

More information: https://clinicaltrials.gov/study/NCT05726708

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child has been diagnosed with Autism Spectrum Disorder (ASD)
The child is between 2 years old and 4 years and 6 months old
The family speaks French
A parent or guardian has signed the consent form to agree to participate

Who may not be able to join:

The child has a known genetic condition or syndrome
The child has a known vision or hearing problem
The child has epilepsy (a condition that causes seizures)
The family does not have access to the internet
The family does not speak French

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire Vaudois

Registry

ClinicalTrials.gov

Start date

24 October 2023

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Dyadic Communication Measure for Autism (DCMA) before parental coaching; Dyadic Communication Measure for Autism (DCMA) immediately after the end of parental coaching; Dyadic Communication Measure for Autism (DCMA) 6 months after the end of parental coaching; Brief Observation of Social Communication Change (BOSCC) before parental coaching; Brief Observation of Social Communication Change (BOSCC) immediately after the end of parental coaching; Brief Observation of Social Communication Change (BOSCC) 6 months after the end of parental coaching; Percentage of synchronized communication acts with...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov